← SynDRA
OBATOCLAX
SynDRA canonical compound SYN0008939 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | BCL2 | BCL2L1 | MCL1 |
| Mechanism of action | BCL inhibitor |
All known targets
Mechanisms of action (all sources)
- BCL inhibitor
- BCL2 INHIBITOR
- BCL2L1 INHIBITOR
- MCL1 INHIBITOR
Cross-references
Synonyms
- GX15-070
- CHEMBL408194
- UNII-QN4128B52A
- QN4128B52A
- SCHEMBL631676
- SCHEMBL16340850
- BDBM50376902
- ZINC136873052
- DB12191
- NCGC00387855-01
- BRD-K15600710-066-01-7
- Obatoclax [INN]
- (2Z)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole
- Obatoclax, Free Base
- OBATOCLAX [WHO-DD]
- CHEMBL4525540
- CHEMBL4802292
- 1H-indole, 2-(2-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-
- 2-(2-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-1H-indole
- HY-10969A
- NSC763888
- NSC-763888
- CS-0025474
- 2-[(5Z)-5-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-4-methoxy-pyrrol-2-yl]-1H-indole
- GX-15-070
- GX 05-070
- GX 015-070
- DTXSID701029688
- 2-[5(3,5-dimethyl-1h-pyrrol-2-ylmethylene)-4-methoxy-5h-pyrrol-2-yl]-1h-indole
- 2-[5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxy-2-pyrrolylidene]indole
- SB16622
- NCGC00263166-01
- Q27166369
- 2-[5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole
- 2-[5-[(3,5-Dimethyl-2H-pyrrole-2-ylidene)methyl]-4-methoxy-1H-pyrrole-2-yl]-1H-indole
- SCHEMBL17594467
- ZINC29052268
- Q7074645
- BCP20625
Look up OBATOCLAX in the interactive SynDRA portal →